{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:40:40Z","timestamp":1791196840793,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.genhosppsych.2007.09.007","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T11:43:02Z","timestamp":1208778182000},"page":"284-287","source":"Crossref","is-referenced-by-count":62,"title":["Serotonin syndrome: a complex but easily avoidable condition"],"prefix":"10.1016","volume":"30","author":[{"given":"Yael","family":"Dvir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Smallwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2007.09.007_bib1","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib2","first-page":"1439","article-title":"Serotonin syndrome: a brief review","volume":"168","author":"Birmes","year":"2003","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0165-0327(98)00221-3","article-title":"Mechanism of action of serotonin selective reuptake inhibitors: serotonin receptors and pathways mediate therapeutic effects and side effects","volume":"51","author":"Stahl","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1345\/aph.1D344","article-title":"Serotonin syndrome resulting from coadministration of tramodol, venlafaxine, and mirtazapine","volume":"38","author":"Houlihan","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.neuropharm.2007.07.009","article-title":"Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice","volume":"53","author":"Fox","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib7","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0149-2918(03)80210-2","article-title":"Venlafaxine: a 2003 update","volume":"25","author":"Gutierrez","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1345\/aph.1C021","article-title":"Serotonin syndrome induced by low-dose venlafaxine","volume":"37","author":"Pan","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib9","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1345\/aph.1C091","article-title":"Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine","volume":"36","author":"Dougherty","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.genhosppsych.2007.09.007_bib10","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1176\/appi.ajp.159.4.672-a","article-title":"Serotonin syndrome and atypical antipsychotics","volume":"159","author":"Duggal","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/bja\/aei210","article-title":"Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity","volume":"95","author":"Gillman","year":"2005","journal-title":"Br J Anaesth"},{"issue":"7","key":"10.1016\/j.genhosppsych.2007.09.007_bib12","first-page":"1353","article-title":"Methadone treatment for pain states","volume":"71","author":"Toombs","year":"2005","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.genhosppsych.2007.09.007_bib13","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-199819030-00002","article-title":"Adverse effects of opioid agonists and agonist\u2013antagonists in anaesthesia","volume":"19","author":"Bowdle","year":"1998","journal-title":"Drug Saf"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/229134a0","article-title":"Methadone increases mouse brain 5-hydroxyindoleacetic acid","volume":"229","author":"Bowers","year":"1971","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.genhosppsych.2007.09.007_bib15","first-page":"1263","article-title":"Serotonin and norepinephrine uptake inhibition activity of centrally acting analgesics: structural determinants and role in antinociception","volume":"274","author":"Codd","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.genhosppsych.2007.09.007_bib16","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/00000542-200306000-00033","article-title":"Probable meperidine-induced serotonin syndrome in a patient with a history of fluoxetine use","volume":"#32;98","author":"Tissot","year":"2003","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.genhosppsych.2007.09.007_bib17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1176\/appi.psy.46.3.274","article-title":"Serotonin syndrome associated with linezolid treatment after discontinuation of fluoxetine","volume":"46","author":"Morales","year":"2005","journal-title":"Psychosomatics"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834307001909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834307001909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T17:56:52Z","timestamp":1546106212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834307001909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0163834307001909"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2007.09.007","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}